(Pharma-Essence) Announcement: Board of Directors Resolution to Approve Q1 FY115 Consolidated Financial Report
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Pharma-Essence announced that its consolidated financial report for Q1 FY115 was approved by the Board of Directors on May 11, 115. Revenue for the period was NT$918.059 million and net profit was NT$116.316 million.